How long should a package spend in an aging chamber to represent 730 days of storage? With a 23°C reference, a 55°C chamber and an assumed Q10 of 2.0, the calculation gives approximately 79.44 days, rounded up to an 80-day minimum. These are hypothetical inputs, not prescribed test conditions. Completing that exposure establishes that the planned chamber time has elapsed. Supporting a shelf-life claim also requires a defensible acceleration model, representative samples and evidence that the relevant properties remain acceptable.
The distinction matters before booking laboratory capacity. A precise calculation cannot compensate for a temperature that changes the failure mechanism or an evaluation that misses the defect of concern.
What ASTM F1980 covers
ASTM F1980-21, Standard Guide for Accelerated Aging of Sterile Barrier Systems and Medical Devices, addresses time-related effects on sterile-barrier integrity and packaging-material properties. Its guidance can also be applied to medical devices and device materials, but it does not address package–device interaction compatibility.
Define the endpoint before calculating exposure. A study of a sealed tray might address whether its materials and seals remain suitable after storage. A package-only result cannot establish that the enclosed device still functions, that a medicine retains its specified quality, or that food remains safe and acceptable until its expiry date. Each claim needs evidence addressing that endpoint; using F1980 does not automatically supply it.
Distribution is another separate question. F1980’s scope excludes event-related performance validation such as shipping and handling, and accelerated-aging data do not establish labeled storage conditions. Surviving the aging chamber therefore does not authorize storage at its elevated temperature. The complementary role of transport simulation is discussed in packaging distribution testing.
How Q10 turns a temperature difference into equivalent time
For a thermally activated degradation process, heating increases the rate at which molecular events overcome the energy barrier involved. The response depends on the material and failure mechanism, as explained in NIST’s Arrhenius acceleration model. This is the physical basis for accelerating some aging processes with temperature, rather than simply exposing a package to arbitrary heat.
Q10 expresses the assumed rate multiplier for a 10°C temperature increase. A Q10 of 2.0 means doubling per 10°C: a 20°C increase gives fourfold acceleration, and a 30°C increase gives eightfold acceleration. This constant-Q10 model is a simplified temperature relationship, not a measurement of the package’s actual degradation rate or a full material-specific Arrhenius fit.
The calculation is:
AF = Q10^((TAA - TRT) / 10)
Accelerated duration = target real-time duration / AF
Here, AF is the dimensionless acceleration factor; Q10 is the dimensionless rate multiplier per 10°C; TAA is the accelerated-aging temperature; and TRT is the real-time reference temperature. Enter both temperatures in Celsius. Their difference, divided by 10°C, gives the number of ten-degree intervals. Both durations must use the same unit, such as days.
The model assumes that the relevant aging behavior at the reference temperature can be represented by progressing faster at the chamber temperature. Different deterioration processes need not share one acceleration factor. A single Q10 should therefore be treated as a justified planning assumption for the endpoints being evaluated, rather than an intrinsic constant for the entire package.
Worked example: exactly 730 days
Using the example inputs, the temperature difference is 55 − 23 = 32°C, or 3.2 ten-degree intervals:
AF = 2.0^(32 / 10) = 2^3.2 ≈ 9.18958683997628
Accelerated duration = 730 / 2^3.2 days ≈ 79.4377389007713 days
The expression 730 / 2^3.2 is the exact model result; the decimal is its numerical approximation. Retaining precision until the final scheduling step gives a whole-day minimum of 80 complete 24-hour exposure periods. Rounding to the nearest day would give 79 days, representing only about 725.98 reference-temperature days under the model. Rounding upward avoids that shortfall. It does not provide a quantified allowance for uncertainty in Q10 or material behavior.
In the Accelerated Aging Calculator, enter the target as 730 DAYS, then explicitly set the reference to 23°C, the chamber to 55°C and Q10 to 2.0. PackCalc converts years using 365.25 days and months using 30.4375 days, so entering 2 YEARS or 24 MONTHS instead produces a 730.5-day target. Those are different inputs, even though both examples round to the same whole-day minimum here.
How sensitive is the schedule to its assumptions?
The comparison below changes one input at a time from the example. Every row retains the 730-day target. Displayed factors and durations are rounded; whole-day minimums were calculated from the unrounded results.
| Change from example | AF | Calculated duration, days | Whole-day minimum |
|---|---|---|---|
| None: 23°C reference, 55°C chamber, Q10 2.0 | 9.1896 | 79.44 | 80 |
| Chamber reduced to 50°C | 6.4980 | 112.34 | 113 |
| Chamber increased to 60°C | 12.9960 | 56.17 | 57 |
| Reference increased to 25°C | 8.0000 | 91.25 | 92 |
| Q10 reduced to 1.5 | 3.6601 | 199.45 | 200 |
| Q10 increased to 2.5 | 18.7676 | 38.90 | 39 |
Scroll to compare all columns.
The Q10 rows expose an important distinction in planning. Raising the chamber temperature changes the physical exposure. Raising the assumed Q10 without supporting evidence changes only the amount of acceleration being credited. Selecting 2.5 to obtain a 39-day schedule does not make the package age that quickly.
Likewise, Q10 = 2.0 is not automatically conservative. If the relevant process followed the hypothetical Q10 = 1.5 relationship, the required exposure would be substantially longer. Conservatism depends on the assumption’s relationship to actual behavior. Material characterization, applicable prior studies and comparisons across temperatures can strengthen that justification; a preferred completion date cannot.
The reference temperature also deserves a rationale tied to the intended storage basis. Neither 22°C nor 23°C should be treated as universally mandatory. Lowering the reference merely to gain a larger temperature difference changes what storage condition the calculation represents.
Choose conditions that preserve relevant aging behavior
Evaluate the entire construction before accepting a chamber temperature: tray or film, sealant, adhesive, coating and any included device components. A glass transition involves a change from relatively rigid, glassy behavior toward greater molecular mobility; softening, melting or other transitions can alter how the assembly responds. Consider a seal that creeps under load only at the chamber temperature. Its failure could reflect a chamber-induced condition rather than the storage deterioration being modeled. The Sterilization Packaging Manufacturers Council’s humidity and aging guidance similarly cautions against introducing damage that would not occur during real-time aging.
For planning, review supplier thermal data alongside evidence for the finished, processed construction. Remaining below a known transition does not, by itself, demonstrate that all relevant mechanisms retain the assumed temperature dependence. Where that evidence is weak, investigate a lower temperature or material-specific aging work before committing to the shorter schedule. No single chamber temperature is safe for every construction.
Humidity needs its own decision because it is absent from the Q10 equation. Moisture-dependent degradation, including hydrolysis, cannot be represented simply by specifying temperature. Maintaining the same relative humidity at a higher temperature also changes the water-vapor environment, as the SPMC guidance explains. Select and document humidity conditions for the materials and storage question, including the rationale for any uncontrolled humidity. Deliberately severe moisture exposure may answer an environmental-challenge question without establishing the desired time equivalence. The humidity resource provides further background on the moisture quantities involved.
Sample configuration belongs in this assessment. An empty pouch, a sealed package containing a device and a package inside protective packaging are different experimental configurations. Ask whether omitting an item changes contact, loading or exposure relevant to the endpoint. Document why the chosen configuration represents the claimed system instead of assuming that testing an isolated material establishes the finished package’s behavior.
Build the study around evidence, not just a pull date
Extend the example to a single-use device in a sealed tray. A practical plan would allocate representative, production-equivalent samples to baseline, accelerated and concurrent real-time groups, with the relevant sterilization history documented. Select lots, configurations and sample counts according to the failure risks, manufacturing variation and intended statistical conclusion. Reserve separate specimens where evaluations are destructive. Sample quantity should follow the question being answered, not a convenient number that fits the chamber.
Before exposure, record material identities, package dimensions, sealing and sterilization records, sample traceability and baseline results. Establish which manufacturing or processing event starts the claimed shelf-life clock, and account for prior storage. A baseline taken later should not silently reset that clock. These records make it possible to distinguish a time-related change from differences already present between sample groups.
For chamber execution, specify acceptable temperature and humidity conditions, monitoring, loading arrangement and the basis for demonstrating uniform exposure. Use calibrated measurement and an arrangement that supports airflow. Define equilibration and when credited exposure begins, rather than assuming that insertion immediately exposes every sample to 55°C. Predefine how door openings, interruptions and excursions will be assessed. The 80-day calculation assumes constant conditions; it cannot decide whether a particular deviation warrants additional time or invalidates the exposure.
An intermediate checkpoint at 365 reference-temperature days would require approximately 39.718869 days, rounded up to a 40-day accelerated pull. The final checkpoint remains 80 days. These are elapsed exposure periods, not inclusive calendar-day counts. Matching real-time groups could be evaluated at 365 and 730 days. The intermediate point is an illustrative choice to look for developing changes before the endpoint, not a universally required interval.
Choose evaluations that answer distinct questions. ASTM F88/F88M-23, Standard Test Method for Seal Strength of Flexible Barrier Materials, measures force to separate a seal-containing specimen and identifies its failure mode. A satisfactory result cannot rule out a pinhole elsewhere in the package. Pair the relevant strength or performance measurements with integrity evaluations suited to the materials, geometry and defects of concern. Establish the methods’ suitability and sensitivity rather than treating every available leak test as interchangeable.
Set acceptance criteria before aging: the applicable seal-strength limits and acceptable failure modes, defined visual-defect limits, and no detected leaks at the chosen integrity method’s validated sensitivity. An unchanged average can conceal unacceptable individual results. Specify how individual results and trends will be assessed, and allow any post-exposure conditioning required by the selected evaluation methods so that comparisons are meaningful.
ASTM F1980’s public significance-and-use text calls for parallel real-time studies through the claimed shelf life, with the same evaluation methods used to confirm accelerated results. Shelf-life assignments based on accelerated evidence remain tentative pending real-time completion. Passing the accelerated endpoint is therefore a reason to review the supporting evidence, not to cancel the confirmatory study.
Before authorizing exposure, make the decision traceable: which property must remain acceptable, why these samples and conditions represent it, what result constitutes failure, and who will act if accelerated and real-time findings disagree. With those decisions documented, the calculated duration becomes a usable laboratory commitment rather than an unsupported expiry date.